Are We Being Set Up for Mass Depopulation? Michael Yeadon - Full Interview - Planet Lockdown

Dr. Michael Yeadon is an Allergy & Respiratory Therapeutic Area expert with 23 years in the pharmaceutical industry and has published over 40 original research articles.


Dr. Yeadon is the former VP and CSO (Chief Scientific Officer) of the big pharma giant Pfizer. You can read his full bio here https://cv19news.wixsite.com/main/guests/dr.-mike-yeadon.


This post will be updated continually with new information and videos from and about Dr. Yeadon and his expert testimony on COVID 19, so make sure to check back from time to time for new information.


Biography


Dr. Mike Yeadon is an Allergy & Respiratory Therapeutic Area expert, developed out of deep knowledge of biology & therapeutics and is an innovative drug discoverer with 23 years in the pharmaceutical industry. He trained as a biochemist and pharmacologist, obtaining his PhD from the University of Surrey (UK) in 1988 on the CNS and peripheral pharmacology of opioids on respiration. Dr Yeadon then worked at the Welcome Research Labs with Salvador Moncada with a research focus on airway hyper-responsiveness and effects of pollutants including ozone and working in drug discovery of 5-LO, COX, PAF, NO and lung inflammation. With colleagues, he was the first to detect exhaled NO in animals and later to induce NOS in lung via allergic triggers.

Joining Pfizer in 1995, he was responsible for the growth and portfolio delivery of the Allergy & Respiratory pipeline within the company. During his tenure at Pfizer, Dr Yeadon was responsible for target selection and the progress into humans of new molecules, leading teams of up to 200 staff across all disciplines and won an Achievement Award for productivity in 2008. Under his leadership the research unit invented oral and inhaled NCEs which delivered multiple positive clinical proofs of concept in asthma, allergic rhinitis and COPD. He led productive collaborations such as with Rigel Pharmaceuticals (SYK inhibitors) and was involved in the licensing of Spiriva® and acquisition of the Meridica (inhaler device) company.

Dr. Yeadon has published over 40 original research articles and now consults and partners with a number of biotechnology companies. Before working with Apellis, Dr. Yeadon was VP and Chief Scientific Officer (Allergy & Respiratory Research) with Pfizer. He left Pfizer in 2011 as Vice President & Chief Scientist for Allergy & Respiratory and eventually founded his own biotech company, Ziarco. In 2017 Dr. Yeadon sold Ziarco to Novartis, one of the world's largest pharmaceutical companies.

 

The original source article was here: https://articles.mercola.com/sites/articles/archive/2021/05/15/planet-lockdown.aspx


Analysis by Dr. Joseph Mercola May 15, 2021


Download Transcript


STORY AT-A-GLANCE


  • Michael Yeadon, Ph.D., a life science researcher and former vice-president and chief scientist of allergy and respiratory research at Pfizer, fears the combination of vaccine passports and booster vaccines against SARS-CoV-2 variants may be part of a mass depopulation agenda

  • Asymptomatic spread is a fallacy capitalized upon to spread fear and induce compliance. Only people who have discernible symptoms of a respiratory infection pose any health risk to others, because to be an efficient source of infection, you need a high viral load. If you have a high viral load, your immune system will fight back, which always induces symptoms

  • The myth of asymptomatic spread was used to justify lockdowns, which in turn were a tool get you used to giving up your freedoms and go along with the intentional decimation of the global economy and old way of life, thereby justifying the Great Reset

  • The Great Reset is about transferring global wealth and ownership rights to the technocratic elite, and giving them the power to control the world’s nations

  • Digital vaccine passports will form the foundation of an unprecedented surveillance and control platform into which your entire life will be tied, from health records to biometric ID, to an all-digital centralized banking system and a social credit system, all of which can be turned off in order to coerce you into a particular behavior


 

How do you market and implement a financial system that nobody would want if they understood its full ramifications — a change so huge that it not only would mean the end of currency as we know it, but a total revision of sovereignty and individual rights?


In the interview above, which is part of the full-length documentary “Planet Lockdown,”1 Michael Yeadon, Ph.D., a life science researcher and former vice-president and chief scientist of allergy and respiratory research at Pfizer, shares his views on the COVID-19 pandemic, fast-tracked COVID-19 “vaccines,” the issue of mutated virus variants and the need for booster shots, and how this manufactured crisis is being used to strip us of our civil liberties.


Are You Putting the Pieces Together?

Yeadon has a degree in biochemistry and toxicology and a research-based Ph.D. in respiratory pharmacology. He’s spent 32 years of his career working for large pharmaceutical companies, and 10 years in the biotechnology sector.

“I'm in favor of all modes of new medical treatments, whether they're biologicals or vaccines, small molecules, creams, sprays, ointments, whatever, but I'm fervently against unsafe medicines or medicines used in an inappropriate context,” Yeadon says.
“Some of the things I'm going to say are not favorable to the current crop of gene-based vaccines and it's [because] they're being inappropriately used. I don't think they have a sufficient safety profile to be used as a sort of wide-spectrum public health prophylactic …
A few things have allowed me, I think, to spot what's going on in the world at the moment. One, I've loved biology since I was little. I've been continuing to learn and to apply biology broadly, whether it's pharmacology, biochemistry, molecular biology [or] toxicology. I've got a very broad grounding in all things to do with life science, in terms of health and disease.
[Secondly], one of my former supervisors said that I had a remarkable facility that stood out above the sort of ordinary things you'd have to do to be a vice president or a CEO. He said I was able to spot patterns in sparse data earlier than my peers. So, when there's not enough data for most people to judge what was going on, I would often be able to see it.